Lexicon Pharmaceuticals

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$14,182
$28,866
$1,262
$26,554
Gross Profit
14,172
28,657
1,232
621
EBITDA
-10,463
5,746
-23,284
-20,312
EBIT
-10,614
5,570
-23,460
-20,437
Net Income
-12,769
3,252
-25,295
-33,766
Net Change In Cash
14,182
28,866
1,262
26,554
Free Cash Flow
-23,833
16,993
-43,778
-21,965
Cash
49,656
21,364
62,888
66,656
Basic Shares
363,399
363,570
362,073
361,492

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$31,081
$1,204
$139
$298
Gross Profit
30,465
-57,768
-52,377
-54,748
EBITDA
-184,290
-169,756
-100,033
-86,798
EBIT
-184,824
-170,310
-100,460
-87,090
Net Income
-200,403
-177,119
-101,944
-87,758
Net Change In Cash
31,081
1,204
139
298
Cost of Revenue
-17,720
-62,198
Free Cash Flow
-179,811
-162,367
-90,177
-88,238
Cash
66,656
22,465
46,345
64,065
Basic Shares
320,031
221,130
165,733
145,652

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
-$0.04
2025-06-30
$0.01
2025-03-31
-$0.07